Submit Content
Get the latest delivered to your inbox
Privacy Policy

Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. 

    Illumina Supports Leading German Hospital to Accelerate Genetic Disease Diagnosis in Critically Ill Children Image

    POSTED 

    04-28-22

    Illumina Supports Leading German Hospital to Accelerate Genetic Disease Diagnosis in Critically Ill Children

    Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced an agreement with Germany's Hannover Medical School (Medizinische Hochschule Hannover (MHH)) to implement the use of whole-genome sequencing (WGS) in critically ill children suspected of having ...
    Baby Fitz's Life-Saving Diagnosis Through Whole-Genome Sequencing Image

    POSTED 

    04-26-22

    Baby Fitz's Life-Saving Diagnosis Through Whole-Genome Sequencing

    In June 2019, Christina and Daniel Kettler were barely home from the hospital with their newborn son when they received an urgent phone call.
    Illumina Expands Access to Genomics in Latin America Through New State-of-the-Art Solution Center Image

    POSTED 

    04-14-22

    Illumina Expands Access to Genomics in Latin America Through New State-of-the-Art Solution Center

    Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the launch of its new state-of-the-art Solution Center in São Paulo, Brazil.
    Illumina Releases Annual Corporate Social Responsibility Report Image

    POSTED 

    04-07-22

    Illumina Releases Annual Corporate Social Responsibility Report

    Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today released its annual Corporate Social Responsibility (CSR) Report, highlighting the company's 2021 environmental, social, and governance (ESG) program and commitment to human health.
    How Genomics Will Support Gorilla Conservation Image

    POSTED 

    04-06-22

    How Genomics Will Support Gorilla Conservation

    Dr. Magdalena Bermejo is calling from a 50-square-meter house deep in a rainforest in the Republic of Congo.
    For Kidney Transplant Recipients, a More Accurate and Tailored Care Plan Image

    POSTED 

    04-05-22

    For Kidney Transplant Recipients, a More Accurate and Tailored Care Plan

    For years, clinicians have used genomics to better inform treatment and personalize therapies. Now, Verici Dx, an immunodiagnostics company based in Tennessee (US), wants to turn that personalized medicine lens to a different field: kidney transplants.
    Can Wastewater Surveillance Protect Public Health? Image

    POSTED 

    03-23-22

    Can Wastewater Surveillance Protect Public Health?

    Whether we realize it or not, we leave clues to our health every time we use the bathroom.
    Illumina Celebrates Rare Disease Day Image

    POSTED 

    03-01-22

    Illumina Celebrates Rare Disease Day

    Today and everyday, Illumina recognizes Rare Disease Day 2022.
    Growing Grassroots Support for the Rare Disease Community in Romania Image

    POSTED 

    02-28-22

    Growing Grassroots Support for the Rare Disease Community in Romania

    In 2007, Dorica Dan, the mother of a child with the rare disease Prader Willi Syndrome, envisioned the first and only patient-run reference center for rare diseases in Europe.
     Illumina to Support Neuro Genomics Project at McGill University Image

    POSTED 

    02-14-22

    Illumina to Support Neuro Genomics Project at McGill University

    Today, the Montreal Neurological Institute-Hospital at McGill University (The Neuro) announced a new research collaboration with Illumina, along with Takeda Development Center Americas, Inc., and pharmaceutical powerhouse Roche.
    Illumina logo

    Illumina

    Illumina

    Join today and get the latest delivered to your inbox